Generate a tailored SOP for Dr. Robin Shattock. Improve your application with a focused, well-structured draft.
Professor Robin Shattock is the Head of Mucosal Infection Immunity in the Department of Medicine at Imperial College London. His research focuses on the mechanisms of mucosal infection development and novel preventative strategies suitable for the developing world. He has led the establishment of international collaborations aimed at the preclinical identification, development, and selection of HIV microbicide vaccine candidates prior to formal clinical efficacy trials. Professor Shattock oversees a portfolio of research supported by 26 staff members including researchers, PhD students, clinical trial managers, and project managers. He has published over 160 peer-reviewed articles in his field and has secured funding from various organizations, including the European Commission, Bill & Melinda Gates Foundation, Wellcome Trust, and NIH. His group is responsible for the DNAVAC project, which applies recent technological advances in DNA vaccination and immune monitoring at the single-cell molecular level to probe vaccine-induced antibody responses. Professor Shattock leads multiple collaborative research programs and work packages aimed at accelerating the development of novel immunization technologies and improving vaccine safety.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.